[The prophylactic effect of haptoglobin administration on renal disfunction in endoscopic injection sclerotherapy].
Miyoshi
H
H
Oshiba
S
S
Matsumoto
A
A
Hayashi
K
K
Tei
H
H
D004932:Esophageal and Gastric Varices / Q000628:therapy*; D004945:Esophagoscopy; D006242:Haptoglobins / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D007674:Kidney Diseases / Q000517:prevention & control*; D008875:Middle Aged; D009829:Oleic Acids / Q000008:administration & dosage / Q000009:adverse effects; D012597:Sclerosing Solutions / Q000009:adverse effects*
D006242:Haptoglobins; D009829:Oleic Acids; D012597:Sclerosing Solutions; C033343:ethanolamine oleate